Resveratrol stimulates cyclic AMP response element mediated gene transcription

Molecular Nutrition and Food Research

Volumn 60, Issue 2, 2016, Pages 256-265

  Thiel, Gerald ^a   Rössler, Oliver G ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

ATF2; CAMP response element; CREB; Polyphenol; Resveratrol

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANTINEOPLASTIC AGENT; ATF2 PROTEIN, HUMAN; CREB1 PROTEIN, HUMAN; CURCUMIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FLAVANONE DERIVATIVE; NARINGENIN; QUERCETIN; RESVERATROL; STILBENE DERIVATIVE;

CELL CULTURE; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HEP-G2 CELL LINE; HUMAN; METABOLISM; NEURAL STEM CELL; TRANSCRIPTION INITIATION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 2; ANTICARCINOGENIC AGENTS; CELLS, CULTURED; CURCUMIN; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FLAVANONES; GENE EXPRESSION REGULATION; HEK293 CELLS; HEP G2 CELLS; HUMANS; NEURAL STEM CELLS; QUERCETIN; RESPONSE ELEMENTS; STILBENES; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84945904737     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500607     Document Type: Article

References (46)

1. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V. et al., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220.
2. Bhat, K. P. L., Kosmeder, J. W. II, Pezzuto, J. M., Biological effects of resveratrol. Antioxid. Redox Signal. 2001, 3, 1041-1064.
3. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P. et al., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004, 24, 2783-2840.
4. Baur, J. A., Sinclair, D. A., Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5, 493-506.
5. Thiel, G., Rössler, O. G., Resveratrol stimulates AP-1-regulated gene transcription. Mol. Nutr. Food Res. 2014, 58, 1402-1413.
6. Rössler, O. G., Glatzel, D., Thiel, G., Resveratrol upregulates Egr-1 expression and activity involving extracellular signal-regulated protein kinase and ternary complex factors. Exp. Cell. Res. 2015, 332, 116-127.
7. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D. et al., Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23, 2369-2380.
8. Heynekamp, J. J., Weber, W. M., Hunsaker, L. A., Gonzales, A. M. et al., Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. J. Med. Chem. 2006, 49, 7182-7189.
9. Athar, M., Back, J. H., Kopelovich, L., Bickers, D. R. et al., Multiple molecular targets of resveratrol, Anti-carcinogenic mechanisms. Arch. Biochem. Biophys. 2009, 486, 95-102.
10. Park, H. R., Kong, K. H., Yu, B. P., Mattson, M. P. et al., Resveratrol inhibits the proliferation of neural progenitor cells and hippocampal neurogenesis. J. Biol. Chem. 2012, 287, 42588-42600.
11. Simao, F., Matté, A., Pagnussat, A. S., Netto, C. A. et al., Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways. Eur. J. Neurosci. 2012, 36, 2899-2905.
12. Lin, Y., Chen, F., Zhang, J., Wang, T. et al., Neuroprotective effect of resveratrol on ischemia/reperfusion injury in rats through TRPC6/CREB pathways. J. Mol. Neurosci. 2013, 50, 504-513.
13. Zhao, Y.-N., Li, W.-F., Li, F., Zhang, Z. et al., Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway. Biochim. Biophys. Res. Comm. 2013, 435, 597-602.
14. Johannessen, M., Delghandi, M. P., Moens, U., What turns CREB on ? Cell. Signal. 2004, 16, 1211-1227
15. Barco, A., Kandel, E. R., in: G., Thiel (Ed.), Transcription Factors in the Nervous System - Development, Brain Function, and Diseases, Wiley-VCH Verlag, Weinheim 2006, pp. 207-241.
16. Hirose, N., Maekawa, T., Shinagawa, T., Ishii, S., ATF-2 regulates lipopolysaccharide-induced transcription in macrophage cells. Biochem. Biophys. Res. Comm. 2009, 385, 72-77.
17. Steinmüller, L., Thiel, G., Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2). Biol. Chem. 2003, 384, 667-672.
18. 2+ ions and the transcription factors c-Jun, ATF2, and TCF. Mol. Pharmacol. 2015, 87, 617-628.
19. Bhoumik, A., Fichtman, B., DeRossi, C., Breitwieser, W. et al., Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc. Natl. Acad. Sci. U S A 2008, 105, 1674-1679.
20. Gozdecka, M., Lyons, S., Kondo, S., Taylor, J. et al., JNK suppresses tumor formation via a gene-expression program mediated by ATF2. Cell Rep. 2014, 9, 1361-1374.
21. Thiel, G., Lesch, A., Keim, A., Transcriptional response to calcium-sensing receptor stimulation. Endocrinology 2012, 153, 4716-4728.
22. Al Sarraj, J., Vinson, C., Han, J., Thiel, G., Regulation of GTP cyclohydrolase I gene transcription by basic region leucine zipper transcription factors. J. Cell. Biochem. 2005, 96, 1003-1020.
23. Lois, C., Hong, E. J., Pease, S., Brown, E. J. et al., Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002, 295, 868-872.
24. Thiel, G., Rössler, O. G., Immediate-early transcriptional response to angiotensin II in human adrenocortical cells. Endocrinology 2011, 152, 4211-4223.
25. Thiel, G., Al Sarraj, J., Vinson, C., Stefano, L. et al. Role of basic region leucine zipper transcription factors CREB, CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription. J. Neurochem. 2005, 92, 321-336.
26. Keim, A., Müller, I., Thiel, G., Efficient genetic manipulation of 1321N1 astrocytoma cells using lentiviral gene transfer. J. Neurosci. Methods 2012, 206, 138-142.
27. Thiel, G., Kaufmann, K., Magin, A., Lietz, M. et al., The human transcriptional repressor protein NAB1, expression and biological activity. Biochim. Biophys. Acta 2000, 1493, 289-301.
28. Schoch, S., Cibelli, G., Magin, A., Steinmüller, L. et al., Modular structure of cAMP response element binding protein 2 (CREB2). Neurochem. Int. 2001, 38, 601-608.
29. Zhang, X., Odom, D. T., Koo, S.-H., Conkright, M. D. et al., Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. U S A 2005, 102, 4459-4464.
30. West, A. E., Chen, W. G., Dalva, M. B., Dolmetsch, R. E. et al., Calcium regulation of neuronal gene expression. Proc. Natl. Acad. Sci. USA 2001, 98, 11024-11031
31. 2+-activated, CREB-dependent transcription in astrocytes. Glia 2009, 57, 828-834.
32. Asahara, H., Santoso, B., Guzman, E., Du, K. et al., Chromatin-dependent cooperativity between constitutive and inducible activation domains in CREB. Mol. Cell. Biol. 2001, 21, 7892-7900.
33. Canettieri, G., Morantte, I., Guzmán, E., Asahara, H. et al., Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat. Struct. Biol. 2003, 10, 175-181.
34. Riccio, A., Ahn, S., Davenport, C. M., Blendy, J. A. et al., Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 1999, 286, 2358-2361.
35. Bonni, A., Brunet, A., West, A. E., Datta, S. R. et al., Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286, 1358-1362.
36. Maekawa, T., Shingawa, T., Sano, Y., Sakuma, T. et al., Reduced levels of ATF-2 predispose mice to mammary tumors. Mol. Cell. Biol. 2007, 27, 1730-1744.
37. Maher, P., Dargusch, R., Bodai, L., Gerard, P. E. et al., ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntingtońs disease. Hum. Mol. Genet. 2011; 20, 261-270.
38. Deak, M., Clifton, A. D., Lucocq, J. M., Alessi, D. R., Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 1998, 17, 4426-4441.
39. Wiggin, G. R., Soloaga, A., Foster, J. M., Murray-Tait, V. et al., MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol. Cell. Biol. 2002, 22, 2871-2881.
40. Ha, J., Kim, H. J., Huang, H., Lee, Z. H. et al., Mitogen- and stress-activated protein kinase 1 activates osteoclastogenesis in vitro and affects bone destruction in vivo. J. Mol. Med. 2013, 91, 977-987.
41. Janknecht, R., Regulation of the ER81 transcription factor and ist coactivators by mitogen- and stress-activated protein kinase 1 (MSK1). Oncogene 2003, 22, 746-755.
42. Goldberg, D. M., Yan, J., Soleas, G. J., Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 2003, 36, 79-87.
43. Meng, X., Maliakal, P., Lu, H., Lee, M. J. et al., Urinary and plasma levels of resveratrol and quercetin in human, mice and rats after ingestion of pure compounds and grape juice. J. Agric. Food. Chem. 2004, 52, 935-942.
44. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E. Jr. et al., High absorption but very low bioavaiability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32, 1377-1382.
45. Kondratyuk, T. P., Park, E.-J., Marler, L. E., Ahn, S. et al., Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity. Mol. Nutr. Food Res. 2011, 55, 1249-1265.
46. Mayhoub, A. S., Marler, L., Kondratyuk, T. P., Park, E.-J. et al., Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets. Bioorg. Med. Chem. 2012, 20, 510-520.